$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Incyte公司的培美替尼适用于什么病症?
2025-10-19 11:44:20
Check Details
Incyte公司的培美替尼去哪买的到?
2025-10-19 11:44:20
Check Details
首个胆管癌口服药-Incyte公司的培美替尼
2025-10-19 11:44:20
Check Details
Incyte公司的培美替尼怎么购买?
2025-10-19 11:44:20
Check Details
Incyte公司的培美替尼效果如何?
2025-10-19 11:44:20
Check Details
Incyte公司的培美替尼对胆管癌有多大效果?
2025-10-19 11:44:20
Check Details
Incyte公司的培美替尼保存条件
2025-10-19 11:44:20
Check Details
FDA批准Ivosidenib治疗IDH1+胆管癌的新药申请
2025-10-19 11:44:20
Check Details
胆管癌首个口服靶向药-培美替尼
2025-10-19 11:44:20
Check Details
培美替尼价格多少?在哪买?
2025-10-19 11:44:20
Check Details
培美替尼在国内哪里买的到?
2025-10-19 11:44:20
Check Details
胆管癌新药培美替尼药品说明书
2025-10-19 11:44:20
Check Details
1
2
...
21
22
23
24
25
26
27
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
2
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
3
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
4
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
5
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
6
Adagrasib Medication Management Guide for Special Populations
7
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
8
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
9
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
10
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
11
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
12
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer